Blackstone (NYSE:BX) is planning to secure an $800M loan to finance its acquisition of a stake in a 50-story office building at 1345 Avenue of the Americas in New York City, according to a media ...
Backed by Goldman Sachs, Novo Nordisk’s parent company and others, Newleos Therapeutics debuted Thursday with $94 million and a plan to develop drugs for brain function and health.
The company has assembled a team that hails from DeepMind and Microsoft, AI in drug discovery specialist Exscientia, genomics and machine learning company Zymergen (bought by Ginkgo Bioworks in 2022), ...